Results 101 to 110 of about 4,664 (185)

Technical report on the first clinical use of a bioabsorbable PGA spacer in HDR brachytherapy for recurrent cervical cancer. [PDF]

J Radiat Res
Okuma K, Kiyomatsu T, Takiyama H, Yoshiba A, Inaba K, Kashihara T, Takahashi K, Sakuramachi M, Nagao A, Igaki H.   +9 more
europepmc   +1 more source

Dosimetric Superiority of High-Dose-Rate (HDR) Brachytherapy Using a Surface Mold Applicator for Primary Cutaneous Angiosarcoma of the Scalp. [PDF]

Cureus, 2022
Takase K, Itonaga T, Mikami R, Irisawa R, Saito K.   +4 more
europepmc   +1 more source

AAPM medical physics practice guideline 13.a: HDR brachytherapy, part B. [PDF]

J Appl Clin Med Phys
Richardson SL, Baghwala AK, Cohen GN, Dempsey C, Libby B, Melhus CS, Miller RA, Scanderbeg DJ, Simiele SJ.   +8 more
europepmc   +1 more source

Dosimetric and clinical outcomes study of occult uterine tandem imperfect implantation in HDR-brachytherapy for cervical cancer. [PDF]

Sci Rep
Zhao X, Wu H, Yi R, Chen D, Tang Y, Zhou Q, Zou D.   +6 more
europepmc   +1 more source

Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial. [PDF]

Clin Transl Radiat Oncol, 2023
Beaudry MM, Carignan D, Foster W, Lavallee MC, Aubin S, Lacroix F, Poulin E, Lachance B, Després P, Beaulieu L, Vigneault E, Martin AG.   +11 more
europepmc   +1 more source

Interstitial HDR brachytherapy for anal cancer-results and quality of life. [PDF]

Strahlenther Onkol
Jirkovská M, Stankušová H, Kindlová A, Jirkovský D, Lohynská R.   +4 more
europepmc   +1 more source

Implementation of needle-tracking technology for real-time transrectal ultrasound-guided interstitial gynecological HDR brachytherapy: A feasibility study. [PDF]

J Appl Clin Med Phys
Bloom LH, Ayala-Peacock D, Venkataraman R, Eckroate B, Sanford R, Chino J, Kim Y, Raffi J, Craciunescu O.   +8 more
europepmc   +1 more source

Interstitial HDR Brachytherapy in the Treatment of Non-Melanocytic Skin Cancers around the Eye. [PDF]

Cancers (Basel), 2021
Cisek P, Kieszko D, Bilski M, Dębicki R, Grywalska E, Hrynkiewicz R, Bębnowska D, Kordzińska-Cisek I, Rolińska A, Niedźwiedzka-Rystwej P, Grzybowska-Szatkowska L.   +10 more
europepmc   +1 more source

Dosimetric Comparison of VMAT Alone and VMAT with HDR Brachytherapy Boost Using Clinical and Biological Dose Models in Localized Prostate Cancer. [PDF]

Curr Oncol
Guhlich M, Knaus O, Strauss A, Fischer LA, Fischer J, Bendrich S, Donath S, Dröge LH, Leu M, Rieken S, Uhlig A, Schirmer MA, Hille A.   +12 more
europepmc   +1 more source

Prediction of disease progression indicators in prostate cancer patients receiving HDR-brachytherapy using Raman spectroscopy and semi-supervised learning: a pilot study. [PDF]

Sci Rep, 2022
Milligan K, Deng X, Ali-Adeeb R, Shreeves P, Punch S, Costie N, Crook JM, Brolo AG, Lum JJ, Andrews JL, Jirasek A.   +10 more
europepmc   +1 more source